October 1, 2020 08:00 AM EDTUpdated 09:24 AM
Financing
AI

Bid­ding to be the go-to ge­nomics and da­ta part­ner for drug de­vel­op­ment, Sophia Ge­net­ics rais­es $100M

Jason Mast

Editor

Ju­r­gi Cam­b­long has spent the last decade go­ing from mi­nor fund­ing round to mi­nor fund­ing round for his start­up, Sophia Ge­net­ics, adding hos­pi­tals in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times